Deal Details

Novanta Acquires Riverpoint

Healthcare

Novanta acquisition of Riverpoint, a portfolio company of Arlington

Summary

Novanta Inc. (“Novanta” or the “Company”) (NASDAQ: NOVT) has entered into a definitive agreement to acquire Riverpoint Medical (“Riverpoint”), a portfolio company of Arlington Capital Partners (“Arlington”), for approximately $1.2 billion in cash and a milestone payment of $250 million in the first quarter of 2027. The transaction is subject to various regulatory approvals and customary closing conditions.

Baird served as financial advisor to Novanta on this transaction.

About

Novanta is a leading global supplier of core technology solutions that give medical, life science and advanced industrial original equipment manufacturers a competitive advantage. The Company combines deep proprietary expertise and competencies in precision medicine, precision manufacturing, robotics and automation and advanced surgery with a proven ability to solve complex technical challenges. This enables Novanta to engineer proprietary technology solutions that deliver extreme precision and performance, tailored to customers' demanding applications. The driving force behind Novanta’s growth is the team of innovative professionals who share a commitment to innovation, the Novanta Growth System and customer success. Novanta is headquartered in Bedford, Massachusetts.

Riverpoint is a category leader in high-growth minimally invasive surgical consumables, designing and manufacturing IP-protected, private-label products for leading medical OEM customers. Riverpoint’s portfolio includes suture anchors, implantable materials, sutures and surgical instruments, primarily serving sports medicine and cardiovascular surgery applications. The company’s differentiated position is built on proprietary material science and coating technologies, including osteoconductive materials and coatings, and its ability to own the 510(k) clearance process end-to-end for its customers. Riverpoint is headquartered in Portland, Oregon, with manufacturing operations in Portland, Oregon and San Jose, Costa Rica.

Arlington is a Washington, D.C.-area private investment firm specializing in government-regulated industries. Focused on the healthcare, aerospace and defense and government services and technology sectors, the firm partners with founders and entrepreneurs to build platforms of strategic importance to national priorities. Operating in markets with high barriers to entry, Arlington looks to partner with organizations within these industries that save lives, improve effectiveness and reduce costs. Since inception in 1999, Arlington has invested in over 200 companies and raised over $14 billion in committed capital. The firm is currently investing out of its $6 billion Fund VII. Arlington is headquartered in Bethesda, Maryland.

Healthcare

Novanta acquisition of Riverpoint, a portfolio company of Arlington